REDUCEDT+30
Neurocrine Biosciences Inc · NASDAQ
−994 sh · $155.3K
Filed 15 Sept 2026SEC Form 4view source
Neurocrine Biosciences Inc · NASDAQ
−994 sh · $155.3K
Neurocrine Biosciences Inc · NASDAQ
+1,842 sh
Neurocrine Biosciences Inc · NASDAQ
−3,386 sh · $529.0K
Neurocrine Biosciences Inc · NASDAQ
+6,275 sh